3rd Place: Prevalence of Anxiety, Depression, and Attention Deficit Disorder in Patients with Primary Hyperhidrosis

Main Article Content

Ella Glaser
King Rosemary
Dee Anna Glaser


psychodermatology, hyperhidrosis


Abstract not available. 


1. Doolittle et al. Arch Dermatol Res. 2016;308(10):743-9.

2. Bahar R, Liu Y, Huang Y, et al. The prevalence of anxiety and depression in patients with or
without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75:1126-1133

3. Braganca GM, Lima SO, Pinto Neto AF, Marques LM, Melo EV, Reis FP. Evaluation of
anxiety and depression prevalence in patients with primary severe hyperhidrosis. An Bras
Dermatol. 2014;89:230-235.

4. Weber A, Heger S, Sinkgraven R, Heckmann M, Elsner P, Rzany B. Psychosocial aspects of
patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression
and increased quality of life after treatment with botulinum toxin A. Br J Dermatol.

5. Klein SZ, Hull M, Gillard KK, Peterson-Brandt J. Dermatology and Therapy, 2020;10:1299-

6. Harvard Medical School National Comorbidity Survey (NCS). 2017

7. National Survey on Drug Use and Health (NSDUH) 2019

8. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill
LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. The prevalence and
correlates of adult ADHD in the United States: results from the National Comorbidity Survey
Replication. Am J Psychiatry. 2006 Apr;163(4):716-23.

Most read articles by the same author(s)